Literature DB >> 26919262

Long-term outcomes of covered self-expandable metal stents for treating benign biliary strictures.

Jin-Seok Park1, Sang Soo Lee2, Tae Jun Song2, Do Hyun Park2, Dong-Wan Seo2, Sung Koo Lee2, Seungbong Han3, Myung-Hwan Kim2.   

Abstract

BACKGROUND AND STUDY AIM: Fully covered, self-expandable metal stents (FCSEMSs) are acceptable tools for treating benign biliary stricture (BBS). However, little is known about the long-term outcomes of this technique. The aim of the present study was to evaluate the procedural and long-term outcomes of FCSEMSs for treating BBSs. PATIENTS AND METHODS: A total of 134 consecutive patients (median age 56 years; range 21 - 83) with BBS were retrospectively reviewed. The main outcomes were technical and clinical success, stricture resolution, recurrence, and adverse events. Outcomes were analyzed by reviewing patient medical records.
RESULTS: The success rates of FCSEMS placement and removal were 99.3 % and 98.2 %, respectively. Stricture resolution occurred in 103/132 (78.0 %) of the patients (median stent duration, 93 days; range 1 - 489). The associated factors for stricture resolution were longer stent indwelling period (≥ 120 days) and absence of stent migration. Stricture recurrence was seen in 26/103 patients (25.2 %; 95 % confidence interval [CI] 0.17 - 0.34) within a median of 390 days (range 4 - 903 days). Chronic pancreatitis was associated with stricture recurrence (hazard ratio [HR] 2.59, 95 %CI 1.20 - 5.61; P = 0.02). Stent migration occurred in 41/132 patients (31.1 %; 95 %CI 0.23 - 0.39). The FCSEMS with anchoring flaps appeared to protect against stent migration (HR 0.22, 95 %CI 0.08 - 0.63; P < 0.01).
CONCLUSION: FCSEMSs had a high success rate for BBS resolution. Longer indwelling periods and the absence of stent migration might be important factors for stricture resolution. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2016        PMID: 26919262     DOI: 10.1055/s-0042-101406

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  6 in total

Review 1.  Endoscopic management of biliary strictures after living donor liver transplantation.

Authors:  Takeshi Tsujino; Hiroyuki Isayama; Hirofumi Kogure; Tatsuya Sato; Yousuke Nakai; Kazuhiko Koike
Journal:  Clin J Gastroenterol       Date:  2017-06-09

2.  Pilot Study of Dumbbell-Type Covered Self-Expandable Metal Stent Deployment for Benign Pancreatic Duct Stricture (with Videos).

Authors:  Tadahiro Yamada; Takeshi Ogura; Atsushi Okuda; Miyuki Imanishi; Rieko Kamiyama; Akira Miyano; Nobu Nishioka; Kazuhide Higuchi
Journal:  J Gastrointest Surg       Date:  2018-08-06       Impact factor: 3.452

3.  Efficacy of Biodegradable Polydioxanone and Polylactic Acid Braided Biodegradable Biliary Stents for the Management of Benign Biliary Strictures.

Authors:  Weixing Zhang; Fariha Kanwal; Muhammad Fayyaz Ur Rehman; Xinjian Wan
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.555

Review 4.  Recent advances in the diagnosis and management of chronic pancreatitis.

Authors:  Chang-Il Kwon; Jae Hee Cho; Sung Hoon Choi; Kwang Hyun Ko; Temel Tirkes; Mark A Gromski; Glen A Lehman
Journal:  Korean J Intern Med       Date:  2019-02-25       Impact factor: 2.884

5.  Evaluation of the Feasibility and Effectiveness of Placement of Fully Covered Self-Expandable Metallic Stents via Various Insertion Routes for Benign Biliary Strictures.

Authors:  Ko Tomishima; Shigeto Ishii; Toshio Fujisawa; Muneo Ikemura; Mako Ushio; Sho Takahashi; Wataru Yamagata; Yusuke Takasaki; Akinori Suzuki; Koichi Ito; Keiichi Haga; Kazushige Ochiai; Osamu Nomura; Hiroaki Saito; Tomoyoshi Shibuya; Akihito Nagahara; Hiroyuki Isayama
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

6.  Incidence and Significance of Biliary Stricture in Chronic Pancreatitis Patients Undergoing Extracorporeal Shock Wave Lithotripsy for Obstructing Pancreatic Duct Stones.

Authors:  Jong Jin Hyun; Shayan S Irani; Andrew S Ross; Michael C Larsen; Michael Gluck; Richard A Kozarek
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.